FindTrial
Sign In

Analysis of COVID 19 features in HRCT Chest of patients who have no evidence of Tuberculosis infection and comparison between COVID and Tuberculosis imaging features in COVID patients.

Analysis of COVID 19 with HRCT Chest in IGRA negative patients- A study in a COVID Hospital of Odisha

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029970
Enrollment
50
Registered
2020-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

KIMS Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.COVID 19 positive patients with imaging features suggestive of exposure to M. Tuberculosis. 2.Those COVID positive patients who have undergone both HRCT and IGRA.

Exclusion criteria

Exclusion criteria: COVID 19 negative patients Absence of any evidence of TB on imaging Those who have not undergone IGRA Those who have refused IV contrast study when indicated.

Design outcomes

Primary

MeasureTime frame
The cases were evaluated by a panel of skilled radiologists for identifying the imaging characteristics to develop a generalised protocol to differentiate COVID-19 from TB in Indian populationTimepoint: 6 months—

Secondary

MeasureTime frame
To assess the prevalence of TB as co-morbidity with COVID in the study population.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Sudhansu Sekhar Mohanty

Kalinga institute of medical sciences

sudhansumohanty2009@gmail.com9994663960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026